Browsing: Therapies

While sparsentan blocks both ETA and AT1 receptors, atrasentan (Vanrafia) is a targeted therapy that focuses only on ETA receptors.…

Several oral and injectable medications have also been approved to help manage atopic dermatitis symptoms such as itching.BiologicsBiologics target specific…

For people living with primary immunodeficiency (PI) , immunoglobulin replacement therapy (Ig) is a cornerstone of treatment. It helps prevent…

Your individual CIDP treatment plan will depend on factors such as symptom severity, nerve damage, and what your doctor thinks…

For more than 20 years, menopausal hormone therapy carried the U.S. Food and Drug Administration’s (FDA) most serious safety notice:…

The U.S. Food and Drug Administration (FDA) is removing the black box safety warning from hormone therapies containing estrogen that…